Preclinical assessment of novel BRAF inhibitors: integrating pharmacokinetic-pharmacodynamic modelling in the drug discovery process

By Choo Edna F   Alicke Bruno   Boggs Jason   Dinkel Vikki   Gould Stephen   Grina Jonas   West Kristina   Menghrajani Kapil   Ran Yingqing   Rudolph Joachim   Wenglowsky Steve  

Xenobiotica, Vol. 41, Iss. 12, 2011-12 ,pp. : 1076-1087

Informa Healthcare

Access to resources Recommend Favorite

Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp study

By Tornøe Christoffer Wenzel   Jacobsen Judith L.   Madsen Henrik  

Journal of Mathematical Biology, Vol. 48, Iss. 6, 2004-06 ,pp. : 591-604

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and Ginkgo biloba extracts in healthy subjects

By Dai Ling-Ling   Fan Lan   Wu Hui-Zi   Tan Zhi-Rong   Chen Yao   Peng Xiang-Dong   Shen Min-Xue   Yang Guo-Ping   Zhou Hong-Hao  

Xenobiotica, Vol. 43, Iss. 10, 2013-10 ,pp. : 862-867

Informa Healthcare

Access to resources Recommend Favorite

The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P₁ agonists

By Taylor Simon   Gray James R. J.   Willis Robert   Deeks Nigel   Haynes Andrea   Campbell Colin   Gaskin Pam   Leavens Karen   Demont Emmanuel   Dowell Simon   Cryan Jenni   Morse Mary   Patel Aarti   Garden Helen   Witherington Jason  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 671-686

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats

By Bertera Facundo   Di Verniero Carla Andrea   Mayer Marcos Alejandro   Chiappetta Diego   Buontempo Fabián   Polizio Ariel Héctor   Taira Carlos Alberto   Höcht Christian  

Xenobiotica, Vol. 42, Iss. 2, 2012-02 ,pp. : 206-219

Informa Healthcare

Access to resources Recommend Favorite